Inherited chromosomally-integrated human herpesvirus 6: epidemiology and disease associations Ruth Jarrett MRC-University of Glasgow Centre for Virus Research.

Slides:

Advertisements

Similar presentations

© 2009 NHS National Genetics Education and Development CentreGenetics and Genomics for Healthcare This PowerPoint file contains.

Advertisements

IWPLS'09 - International Workshop on Portals for Life Sciences Generation Scotland Data Access Portal Archie Campbell Data Analyst / Programmer Generation.

HIV – Human Immunodeficiency Virus Spherical (~0.1µm Ø) Glycoprotein envelope with protein knobs on surface. Core is cone-shaped & contains RNA and the.

HPV.  Many risk factors for development of cervical cancer. no routinely used positive predictive biological markers, which identify women at risk of.

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.

Viral Infection Detection. Clinical examinations & findings Antibody detection Electron Microscopic: SEM & TEM Molecular assays: PCR Detection of viral.

TELOMERES What are they? Why are they important? Telomere shortening and the end-replication problem Telomerase Telomere hypothesis of aging.

CANCER IS A GENETIC DISEASE SUPPORTING EVIDENCE: 1. Hereditary cancer 2. Cancer-causing virus 3. Alterations of cellular genes in cancer 4. Clonal development.

Genetic Testing in Genomic Medicine Gail H. Vance M.D. Professor, Department of Medical & Molecular Genetics Indiana University School of Medicine.

 Primary liver cancer is the fifth most common cancer in the world and the third most common cause of cancer mortality  Hepatocellular carcinomas (HCCs)

Replication of Small DNA Virus

Download lecture at: flemingtonlab.com

WTCRF Nursing & Clinical Epidemiology & Statistics Image Analysis

21 August 2015 Samreen Ijaz Virus Reference Department Health Protection Agency Indigenous HEV infection in the UK: a hazard for blood donation?

KEY CONCEPT Genetics provides a basis for new medical treatments.

The disease and Panbio product training HHV-6. Overview First isolated in 1986 from patients with AIDS The main clinical syndrome associated with the.

Applications of molecular techniques used in research.

Herpesviruses. 100 nm Herpesvirus structures are unique, with tegument layer present and genomic DNA wrapped around core.

Oncogenic viruses DNA viruses Herpesviridae Papovaviridae

Biotechnology SB2.f – Examine the use of DNA technology in forensics, medicine and agriculture.

Lara Isobel Compston, Daniel Candotti, Jean-Pierre Allain

Hepatitis B Virus Dr R V S N Sarma., M.D., [SLIDE 1] Title Slide

Fungal Research Trust activities Aim to Build a Centre of Excellence – Direct research support – Direct clinical fungal lab support – Postgraduate training.

Herpes Viruses Herpes zoster

A vaccine is biological preparation that improves immunity to a particular disease, a vaccine typically contains a disease causing micro-organisms often.

Population Dynamics Humans and malaria. Science (2010), v.328:841.

The Biology and Genetic Base of Cancer. 2 (Mutation)

Investigating Intestinal Alkaline Phosphatase as a Risk Factor for Inflammatory Bowel Disease Vanessa Danquah Guillemin Lab Guillemin Lab.

Urban-Rural Inequalities in Potentially Preventable Hospital Admissions Carolyn Hunter-Rowe Senior Health Intelligence Analyst Department of Public Health.

INTRODUCTION TO PEDIATRIC ONCOLOGY Prof.Dr.Reha Cengizlier

 How does DNA help us in medicine? QOTD. Mr.Dunnum DNA TECHNOLOGY.

Chapter 13-Viruses of Bacteria. General Characteristics of all viruses Contain a single type of nucleic acid Contain a protein coat Obligate intracellular.

ImmunoPathogenesis of HIV Disease Overview of HIV Epidemic Basic biology of HIV-1 Stages of HIV Disease Viral and Cellular Dynamics after HAART HIV Therapy.

Analysis of Recombination in the HIV-1pol Gene Richard Myers Division of Infection and Immunity University College London.

HBV (chronic) HIV ~400 million chronically infected

TELOMERES &TELOMERASE 18 th Lecture Gihan E-H Gawish, MSc, PhD Ass. Professor Molecular Genetics and Clinical Biochemistry Molecular Genetics and Clinical.

Cancers of the Digestive System November 19, 2007 NCDD Meeting Chair: John M. Carethers, MD Vice Chair: Robert Sandler, MD, MPH.

Brainstorming. For each part, you should indicate whether you think it is true (T), false (F), or don’t know (DN). 1. Viruses Contain both DNA and RNA.

Chromatin Structure and Replication

Microbial Genetics.  In bacteria genetic transfer (recombination) can happen three ways:  Transformation  Transduction  Conjugation  The result is.

Infection STrategies Lytic Cycle: – The virus enters the cell, makes copies of itself and causes the cell to burst. Uses the materials and cell machinery.

In most gene therapy studies, a "normal" gene is inserted into the genome to replace an "abnormal," disease-causing gene. A carrier molecule called a.

CATEGORY: VACCINES & THERAPEUTICS HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK HIV-1 Vaccines © The copyright for this work resides.

Evidence for optimizing highly active antiretroviral treatment (HAART) in Kenya Dr. Washingtone Ochieng CNHR RCDG Fellow returning from Harvard University,

© 2010 Jones and Bartlett Publishers, LLC. Chapter 12 Clinical Epidemiology.

Viral transformation and oncogenesis

Generation Scotland Cognitive Expert Working Group Ian Deary & Riccardo Marioni et al.

Fahareen-Binta-Mosharraf MNS. Disease-causing viruses often grouped by their route of transmission Enteric viruses Generally transmitted via fecal-oral.

Chapter 8: Genetic Epidemiology. Introduction Scientific advancement in genetics – Mendel’s laws of inheritance – Charles Darwin’s observations – Discovery.

APPLICATIONS OF ANIMAL CELL CULTURE

La nuova biologia.blu Anatomia e fisiologia dei viventi S

HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK

I. Viral Genomes.

Polymerase Chain Reaction

9.11 Viruses That Use Reverse Transcriptase

New genes can be added to an organism’s DNA.

Presentation Topic Cloning Vector and its Types Presented By

Virology Herpesviruses Asst. Prof. Dr. Dalya Basil

KEY CONCEPT Genetics provides a basis for new medical treatments.

D.A. Clark Clinical Microbiology and Infection

Sirulins A&S Jim Lund Leonard Guarente

KEY CONCEPT Genetics provides a basis for new medical treatments.

KEY CONCEPT Genetics provides a basis for new medical treatments.

Skin Diseases Associated with Human Herpesvirus 6, 7, and 8 Infection

Engineering Viral Genomes: Adeno-Associated Vectors

Epigenetics and Genetics of Viral Latency

KEY CONCEPT Genetics provides a basis for new medical treatments.

KEY CONCEPT Genetics provides a basis for new medical treatments.

KEY CONCEPT Genetics provides a basis for new medical treatments.

Presentation transcript:

Inherited chromosomally-integrated human herpesvirus 6: epidemiology and disease associations Ruth Jarrett MRC-University of Glasgow Centre for Virus Research

Human herpesvirus 6 Two distinct but closely related herpesviruses – HHV-6A and HHV-6B Most individuals are infected in early childhood Virus persists for life and can be reactivated HHV-6B more prevalent in Europe, the USA and Japan HHV-6A relatively more common in Africa?

HHV-6 and disease Primary infection by HHV-6B causes roseola infantum and common cause of febrile seizures Reactivation rarely problematic in immunocompetent individuals In immunosuppressed individuals reactivation is associated with encephalitis, colitis, hepatitis etc. Many other associations – mesial temporal lobe epilepsy, MS, myocarditis and cardiomyopathy, low Bayley scores – reported but not proven

HHV-6 integrates into telomeres Direct repeat (DR) Unique region 162 kb of herpesvirus genome integrated in telomere Homologous recombination Host telomere Perfect and imperfect telomere-like repeats Perfect and imperfect telomere-like repeats

Integrated HHV-6 can be excised Chromosomally integrated HHV-6 can reactivate in vivo Excised viral genomes detected in vitro Chromosomally integrated HHV-6 may be a form of latent viral infection

Exogenous HHV-6 infection ? Non-heritable Inherited HHV-6 (iciHHV-6) HHV-6 DNA Heritable HHV-6 DNA

Sudden telomere shortening Influence on expression of sub-telomeric genes Inflammation Senescence Telomere fusion Altered cellular gene expression Chromosome- specific Viral reactivation Drugs HDAC inhibitors

Inherited HHV-6 (iciHHV-6) HHV-6 DNA Heritable Consequences of iciHHV-6? Viral reactivation Age-related disease Cancer

iciHHV-6 in GS:SFHS: Aims To explore clinical relevance To determine the prevalence of iciHHV-6 in a large population-based study determine whether HHV-6A or HHV-6B To determine whether chromosomal integration is random To analyse viral evolution evidence of new integrations timing of integration events

Detection of iciHHV-6 in the GS:SFHS TaqMan screen HHV-6 DR1/ β-globin ddPCR HHV-6B DR6 RPP30 If negative ddPCR HHV-6A DR6 ddPCR HHV-6 U7 RPP30 TaqMan HHV-6A pol TaqMan HHV-6B pol

Conclusions Analysis of iciHHV-6 in the GS:SFHS has uncovered some unexpected findings Regional differences in the iciHHV-6 prevalence in the UK were detected iciHHV-6 is associated with an increased risk of some disease symptoms

Acknowledgements University of Glasgow CVR Adam Bell Chris Brownlie Skye Storrie Andrew Davison Rob Gifford ICAMS Christian Delles Barts Health NHS Trust Duncan Clark BGS, ICR Anthony Swerdlow Nick Orr Archie Campbell Caroline Hayward Carmen Amador Shona Kerr Pamela Linksted David J Porteous Blair H Smith Lynne Hocking Sandosh Padmanabhan Edinburgh Clinical Research Facility Lee Murphy Angie Fawkes